Portal vein thrombosis risk factors: Difference between revisions
Jump to navigation
Jump to search
Farima Kahe (talk | contribs) |
Farima Kahe (talk | contribs) |
||
| Line 24: | Line 24: | ||
*Common risk factors in the development of [disease name] include [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4]. | *Common risk factors in the development of [disease name] include [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4]. | ||
===Common Risk Factors=== | ===Common Risk Factors=== | ||
*Common risk factors in the development of toxic megacolon include:<ref name="SogaardAstrup2007">{{cite journal|last1=Sogaard|first1=Kirstine K|last2=Astrup|first2=Lone B|last3=Vilstrup|first3=Hendrik|last4=Gronbaek|first4=Henning|title=Portal vein thrombosis; risk factors, clinical presentation and treatment|journal=BMC Gastroenterology|volume=7|issue=1|year=2007|issn=1471-230X|doi=10.1186/1471-230X-7-34}}</ref> | *Common risk factors in the development of toxic megacolon include:<ref name="SogaardAstrup2007">{{cite journal|last1=Sogaard|first1=Kirstine K|last2=Astrup|first2=Lone B|last3=Vilstrup|first3=Hendrik|last4=Gronbaek|first4=Henning|title=Portal vein thrombosis; risk factors, clinical presentation and treatment|journal=BMC Gastroenterology|volume=7|issue=1|year=2007|issn=1471-230X|doi=10.1186/1471-230X-7-34}}</ref><ref name="pmid20474001">{{cite journal |vauthors=Kinjo N, Kawanaka H, Akahoshi T, Tomikawa M, Yamashita N, Konishi K, Tanoue K, Shirabe K, Hashizume M, Maehara Y |title=Risk factors for portal venous thrombosis after splenectomy in patients with cirrhosis and portal hypertension |journal=Br J Surg |volume=97 |issue=6 |pages=910–6 |year=2010 |pmid=20474001 |doi=10.1002/bjs.7002 |url=}}</ref><ref name="pmid25941431">{{cite journal |vauthors=Chawla YK, Bodh V |title=Portal vein thrombosis |journal=J Clin Exp Hepatol |volume=5 |issue=1 |pages=22–40 |year=2015 |pmid=25941431 |pmc=4415192 |doi=10.1016/j.jceh.2014.12.008 |url=}}</ref><ref name="pmid28621635">{{cite journal |vauthors=Montenovo M, Rahnemai-Azar A, Reyes J, Perkins J |title=Clinical Impact and Risk Factors of Portal Vein Thrombosis for Patients on Wait List for Liver Transplant |journal=Exp Clin Transplant |volume= |issue= |pages= |year=2017 |pmid=28621635 |doi=10.6002/ect.2016.0277 |url=}}</ref><ref name="pmid2806552">{{cite journal |vauthors=Zhang WW, Churchill S, Churchill P |title=Developmental regulation of D-beta-hydroxybutyrate dehydrogenase in rat liver and brain |journal=FEBS Lett. |volume=256 |issue=1-2 |pages=71–4 |year=1989 |pmid=2806552 |doi= |url=}}</ref> | ||
**Prothrombotic disorder | **Prothrombotic disorder | ||
***Hyperhomocysteinemia | ***Hyperhomocysteinemia | ||
Revision as of 20:50, 28 November 2017
|
Portal vein thrombosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Portal vein thrombosis risk factors On the Web |
|
American Roentgen Ray Society Images of Portal vein thrombosis risk factors |
|
Risk calculators and risk factors for Portal vein thrombosis risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
There are no established risk factors for [disease name].
OR
The most potent risk factor in the development of [disease name] is [risk factor 1]. Other risk factors include [risk factor 2], [risk factor 3], and [risk factor 4].
OR
Common risk factors in the development of [disease name] include [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].
OR
Common risk factors in the development of [disease name] may be occupational, environmental, genetic, and viral.
Risk Factors
- There are no established risk factors for [disease name].
OR
- The most potent risk factor in the development of [disease name] is [risk factor 1]. Other risk factors include [risk factor 2], [risk factor 3], and [risk factor 4].
- Common risk factors in the development of [disease name] include [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].
Common Risk Factors
- Common risk factors in the development of toxic megacolon include:[1][2][3][4][5]
- Prothrombotic disorder
- Hyperhomocysteinemia
- Antiphospholipid syndrome
- Hormone replacement therapy
- Factor V Leiden mutation
- Protein C deficiency
- Polycythaemia vera
- Myeloproliferative syndrome
- Protein S deficiency
- Antitrombin III deficiency
- Disseminated coagulation
- Essential thrombocytosis
- Abdominal inflammation
- Chronic pancreatitis
- Cholangitis
- Acute pancreatitis
- Liver abscesses
- mbilical vein catheterization
- Cholecystolithiasis
- Polycystic liver disease
- Cirrhosis
- Prothrombotic disorder
Less Common Risk Factors
- Less common risk factors in the development of [disease name] include:
- Cancer
- Neuro-endocrine tumor
- Hepatocellular carcinoma
- Pancreatic cancer
- Angiomyxoma
- Unknown primary tumour
- Abdominal intervention
- Splenectomy
- Cholecystectomy
- Billroth II
- Radiofrequency ablation
- Gastropancreaticcystotomy
- Abdominal infection
- Bacteraemia
- Portal vein phlebitis
- Intestinal tuberculosis
- Sepsis
- Tuberculosis in psoas abscess
- Cancer
References
- ↑ Sogaard, Kirstine K; Astrup, Lone B; Vilstrup, Hendrik; Gronbaek, Henning (2007). "Portal vein thrombosis; risk factors, clinical presentation and treatment". BMC Gastroenterology. 7 (1). doi:10.1186/1471-230X-7-34. ISSN 1471-230X.
- ↑ Kinjo N, Kawanaka H, Akahoshi T, Tomikawa M, Yamashita N, Konishi K, Tanoue K, Shirabe K, Hashizume M, Maehara Y (2010). "Risk factors for portal venous thrombosis after splenectomy in patients with cirrhosis and portal hypertension". Br J Surg. 97 (6): 910–6. doi:10.1002/bjs.7002. PMID 20474001.
- ↑ Chawla YK, Bodh V (2015). "Portal vein thrombosis". J Clin Exp Hepatol. 5 (1): 22–40. doi:10.1016/j.jceh.2014.12.008. PMC 4415192. PMID 25941431.
- ↑ Montenovo M, Rahnemai-Azar A, Reyes J, Perkins J (2017). "Clinical Impact and Risk Factors of Portal Vein Thrombosis for Patients on Wait List for Liver Transplant". Exp Clin Transplant. doi:10.6002/ect.2016.0277. PMID 28621635.
- ↑ Zhang WW, Churchill S, Churchill P (1989). "Developmental regulation of D-beta-hydroxybutyrate dehydrogenase in rat liver and brain". FEBS Lett. 256 (1–2): 71–4. PMID 2806552.